Does fast injection of therapeutic liquids lead to reduction in admission rate of children with gastroenteritis?

Effect of fast intravenous serum therapy on hospital admisson rate of children with refractory vomitting and gastroenteritis referring to Tabriz Children's Hospital

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201110247892N1

Enrollment

Registered

2012-05-03

Start date

2012-04-02

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infective gastroenteritis. Other and unspecified gastroenteritis of infectious origin

Interventions

Intervention 1: Control group: Patients in this group will be admitted to the internal ward of the hospital and treated as appropriate. Intervention 2: Intervention group: patients in this group will

Treatment - Drugs

Control group: Patients in this group will be admitted to the internal ward of the hospital and treated as appropriate

Intervention group: patients in this group will receive an intravenous crystalloid 30 ml/kg within 2 hours and then visited by a pediatrician to see if they need a hospital admission to internal wards

Eligibility

Sex/Gender

All

Age

2 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: (2 to 12 year old children with diarrhea and vomiting which have not responded well to routine oral therapies; not to have electrolite imbalance; not to have severe dehydration; to fulfill an informed consent) Exclusion criteria: (patients with mild or severe dehydration; to have electorlite imbalance; in shock patients; patients with vomiting or diarrhea alone)

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Skin turgor. Timepoint: At the first time visited in the emergency ward, after receiving intravenous therapy. Method of measurement: Physical examination by a pediatrician.;Mucosal dryness. Timepoint: At the first time visited in the emergency ward, after receiving intravenous therapy. Method of measurement: Physical examination by a peditrician.;Desire to drink water. Timepoint: At the first time visited in the emergency ward, after receiving intravenous therapy. Method of measurement: Physical examination by a pediatrician.	—

Measure

Time frame

Skin turgor. Timepoint: At the first time visited in the emergency ward, after receiving intravenous therapy. Method of measurement: Physical examination by a pediatrician.;Mucosal dryness. Timepoint: At the first time visited in the emergency ward, after receiving intravenous therapy. Method of measurement: Physical examination by a peditrician.;Desire to drink water. Timepoint: At the first time visited in the emergency ward, after receiving intravenous therapy. Method of measurement: Physical examination by a pediatrician.

—

Secondary

Measure	Time frame
Vomiting. Timepoint: While receiving intravenous serum or after receiving it. Method of measurement: Objective observation by a pediatrician.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAnoosh Azarfar

Tabriz University of Medical Sciences

azarfar132@yahoo.com+98 41 1658 4153

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026